{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:48:31Z","timestamp":1792180111949,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Osteoarthritis (OA) is the most common degenerative disease in joints among elderly patients. Senescence is deeply involved in the pathogenesis of osteoarthritis. Metformin is widely used as the first-line drug for Type 2 diabetes mellitus (T2DM), and has great potential for the treatment of other aging-related disorders, including OA. However, the role of metformin in OA is not fully elucidated. Therefore, our aim here was to investigate the effects of metformin on human chondrocytes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>After metformin treatment, expression level of microRNA-34a and SIRT1 in chondrocyte were detected with quantitative real-time PCR and immunofluorescence staining. Then, microRNA-34a mimic and small interfering RNA (siRNA) against SIRT1 (siRNA-SIRT1) were transfected into chondrocyte. Senescence-associated \u03b2-galactosidase (SA-\u03b2-gal) staining was performed to assess chondrocyte senescence. Chondrocyte viability was illustrated with MTT and colony formation assays. Western blot was conducted to detect the expression of P16, IL-6, matrix metalloproteinase-13 (MMP-13), Collagen type II (COL2A1) and Aggrecan (ACAN).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that metformin treatment (1\u00a0mM) inhibited microRNA-34a while promoted SIRT1 expression in OA chondrocytes. Both miR-34a mimics and siRNA against SIRT1 inhibited SIRT1 expression in chondrocytes. SA-\u03b2-gal staining assay confirmed that metformin reduced SA-\u03b2-gal-positive rate of chondrocytes, while transfection with miR-34a mimics or siRNA-SIRT1 reversed it. MTT assay and colony formation assay showed that metformin accelerated chondrocyte proliferation, while miR-34a mimics or siRNA-SIRT1 weakened this effect. Furthermore, results from western blot demonstrated that metformin suppressed expression of senescence-associated protein P16, proinflammatory cytokine IL-6 and catabolic gene MMP-13 while elevated expression of anabolic proteins such as Collagen type II and Aggrecan, which could be attenuated by transfection with miR-34a mimics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Overall, our data suggest that metformin regulates chondrocyte senescence and proliferation through microRNA-34a\/SIRT1 pathway, indicating it could be a novel strategy for OA treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13018-023-03571-5","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:28:21Z","timestamp":1679862501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Metformin regulates chondrocyte senescence and proliferation through microRNA-34a\/SIRT1 pathway in osteoarthritis"],"prefix":"10.1186","volume":"18","author":[{"given":"Shiju","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"issue":"9991","key":"3571_CR1","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","volume":"386","author":"S Glyn-Jones","year":"2015","unstructured":"Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, Carr AJ. Osteoarthritis. Lancet. 2015;386(9991):376\u201387.","journal-title":"Lancet"},{"issue":"3","key":"3571_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/ar2655","volume":"11","author":"SB Abramson","year":"2009","unstructured":"Abramson SB, Attur M. Developments in the scientific understanding of osteoarthritis. Arthritis Res Ther. 2009;11(3):227.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3571_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/bmb\/ldz015","volume":"130","author":"A Oliviero","year":"2019","unstructured":"Oliviero A, Della PG, Peretti GM, Maffulli N. MicroRNA in osteoarthritis: physiopathology, diagnosis and therapeutic challenge. Br Med Bull. 2019;130(1):137\u201347.","journal-title":"Br Med Bull"},{"issue":"9","key":"3571_CR4","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1002\/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I","volume":"43","author":"MB Goldring","year":"2000","unstructured":"Goldring MB. The role of the chondrocyte in osteoarthritis. Arthritis Rheum. 2000;43(9):1916\u201326.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3571_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2174\/138945007779940070","volume":"8","author":"T Aigner","year":"2007","unstructured":"Aigner T, Haag J, Martin J, Buckwalter J. Osteoarthritis: aging of matrix and cells\u2013going for a remedy. Curr Drug Targets. 2007;8(2):325\u201331.","journal-title":"Curr Drug Targets"},{"issue":"8","key":"3571_CR6","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.2337\/diabetes.51.8.2420","volume":"51","author":"SA Hawley","year":"2002","unstructured":"Hawley SA, Gadalla AE, Olsen GS, Hardie DG. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes. 2002;51(8):2420\u20135.","journal-title":"Diabetes"},{"key":"3571_CR7","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3389\/fphys.2018.01857","volume":"9","author":"JS Teodoro","year":"2018","unstructured":"Teodoro JS, Nunes S, Rolo AP, Reis F, Palmeira CM. Therapeutic options targeting oxidative stress, mitochondrial dysfunction and inflammation to hinder the progression of vascular complications of diabetes. Front Physiol. 2018;9:1857.","journal-title":"Front Physiol"},{"issue":"10","key":"3571_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.334","volume":"7","author":"D Chen","year":"2016","unstructured":"Chen D, Xia D, Pan Z, Xu D, Zhou Y, Wu Y, Cai N, Tang Q, Wang C, Yan M, et al. Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo. Cell Death Dis. 2016;7(10): e2441.","journal-title":"Cell Death Dis"},{"issue":"7764","key":"3571_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41586-019-1365-2","volume":"571","author":"J Campisi","year":"2019","unstructured":"Campisi J, Kapahi P, Lithgow GJ, Melov S, Newman JC, Verdin E. From discoveries in ageing research to therapeutics for healthy ageing. Nature. 2019;571(7764):183\u201392.","journal-title":"Nature"},{"issue":"1","key":"3571_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13075-020-2129-y","volume":"22","author":"H Li","year":"2020","unstructured":"Li H, Ding X, Terkeltaub R, Lin H, Zhang Y, Zhou B, He K, Li K, Liu Z, Wei J, et al. Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior. Arthritis Res Ther. 2020;22(1):34.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"3571_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3892\/etm.2022.11146","volume":"23","author":"J Yan","year":"2022","unstructured":"Yan J, Ding D, Feng G, Yang Y, Zhou Y, Ma L, Guo H, Lu Z, Jin Q. Metformin reduces chondrocyte pyroptosis in an osteoarthritis mouse model by inhibiting NLRP3 inflammasome activation. Exp Ther Med. 2022;23(3):222.","journal-title":"Exp Ther Med"},{"issue":"2","key":"3571_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"issue":"7006","key":"3571_CR13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350\u20135.","journal-title":"Nature"},{"issue":"1","key":"3571_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/bmb\/ldaa002","volume":"133","author":"L Giordano","year":"2020","unstructured":"Giordano L, Porta GD, Peretti GM, Maffulli N. Therapeutic potential of microRNA in tendon injuries. Br Med Bull. 2020;133(1):79\u201394.","journal-title":"Br Med Bull"},{"issue":"2","key":"3571_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000454874","volume":"22","author":"Q Huang","year":"2017","unstructured":"Huang Q, Ou Y, Xiong H, Yang H, Zhang Z, Chen S, Ye Y, Zheng Y. The miR-34a\/Bcl-2 pathway contributes to auditory cortex neuron apoptosis in age-related hearing loss. Audiol Neurootol. 2017;22(2):96\u2013103.","journal-title":"Audiol Neurootol"},{"issue":"1","key":"3571_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10238-019-00593-4","volume":"20","author":"J Banerjee","year":"2020","unstructured":"Banerjee J, Roy S, Dhas Y, Mishra N. Senescence-associated miR-34a and miR-126 in middle-aged Indians with type 2 diabetes. Clin Exp Med. 2020;20(1):149\u201358.","journal-title":"Clin Exp Med"},{"issue":"1","key":"3571_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3892\/ijmm.2016.2618","volume":"38","author":"S Yan","year":"2016","unstructured":"Yan S, Wang M, Zhao J, Zhang H, Zhou C, Jin L, Zhang Y, Qiu X, Ma B, Fan Q. MicroRNA-34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1\/p53 signaling pathway during the pathogenesis of osteoarthritis. Int J Mol Med. 2016;38(1):201\u20139.","journal-title":"Int J Mol Med"},{"issue":"9","key":"3571_CR18","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1139\/cjpp-2020-0180","volume":"99","author":"W Li","year":"2021","unstructured":"Li W, Jin S, Hao J, Shi Y, Li W, Jiang L. Metformin attenuates ischemia\/reperfusion-induced apoptosis of cardiac cells by downregulation of p53\/microRNA-34a via activation of SIRT1. Can J Physiol Pharmacol. 2021;99(9):875\u201384.","journal-title":"Can J Physiol Pharmacol"},{"issue":"26","key":"3571_CR19","doi-asserted-by":"publisher","first-page":"14670","DOI":"10.1039\/C9RA00705A","volume":"9","author":"L Feng","year":"2019","unstructured":"Feng L, Liu T, Yang Y, Xiao W, Shi J, Mei X, Tian S, Liu X, Huang H, Bai Y. Metformin promotes proliferation and suppresses apoptosis in Ox-LDL stimulated macrophages by regulating the miR-34a\/Bcl2 axis. Rsc Adv. 2019;9(26):14670\u20136.","journal-title":"Rsc Adv"},{"key":"3571_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","volume":"5","author":"MC Haigis","year":"2010","unstructured":"Haigis MC, Sinclair DA. Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol. 2010;5:253\u201395.","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"3571_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.molmed.2017.02.005","volume":"23","author":"R van de Ven","year":"2017","unstructured":"van de Ven R, Santos D, Haigis MC. Mitochondrial sirtuins and molecular mechanisms of aging. Trends Mol Med. 2017;23(4):320\u201331.","journal-title":"Trends Mol Med"},{"issue":"7","key":"3571_CR22","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1136\/annrheumdis-2012-202620","volume":"73","author":"T Matsuzaki","year":"2014","unstructured":"Matsuzaki T, Matsushita T, Takayama K, Matsumoto T, Nishida K, Kuroda R, Kurosaka M. Disruption of Sirt1 in chondrocytes causes accelerated progression of osteoarthritis under mechanical stress and during ageing in mice. Ann Rheum Dis. 2014;73(7):1397\u2013404.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"3571_CR23","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/jcb.29637","volume":"122","author":"S Ni","year":"2020","unstructured":"Ni S, Xu C, Zhuang C, Zhao G, Li C, Wang Y, Qin X. LncRNA LUADT1 regulates miR-34a\/SIRT1 to participate in chondrocyte apoptosis. J Cell Biochem. 2020;122(9):1003\u20138.","journal-title":"J Cell Biochem"},{"issue":"2","key":"3571_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/BOR.0000000000000479","volume":"30","author":"ER Vina","year":"2018","unstructured":"Vina ER, Kwoh CK. Epidemiology of osteoarthritis: literature update. Curr Opin Rheumatol. 2018;30(2):160\u20137.","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"3571_CR25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.5582\/bst.2018.01263","volume":"12","author":"C Wang","year":"2019","unstructured":"Wang C, Yang Y, Zhang Y, Liu J, Yao Z, Zhang C. Protective effects of metformin against osteoarthritis through upregulation of SIRT3-mediated PINK1\/Parkin-dependent mitophagy in primary chondrocytes. Biosci Trends. 2019;12(6):605\u201312.","journal-title":"Biosci Trends"},{"issue":"1","key":"3571_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13075-019-1915-x","volume":"21","author":"Y Wang","year":"2019","unstructured":"Wang Y, Hussain SM, Wluka AE, Lim YZ, Abram F, Pelletier JP, Martel-Pelletier J, Cicuttini FM. Association between metformin use and disease progression in obese people with knee osteoarthritis: data from the Osteoarthritis Initiative-a prospective cohort study. Arthritis Res Ther. 2019;21(1):127.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"3571_CR27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/acel.12469","volume":"15","author":"HN Noren","year":"2016","unstructured":"Noren HN, Martin-Montalvo A, Dluzen DF, Zhang Y, Bernier M, Zonderman AB, Becker KG, Gorospe M, de Cabo R, Evans MK. Metformin-mediated increase in DICER1 regulates microRNA expression and cellular senescence. Aging Cell. 2016;15(3):572\u201381.","journal-title":"Aging Cell"},{"key":"3571_CR28","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.2147\/DDDT.S336490","volume":"15","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Chen R, Deng L, Shuai Z, Chen M. The effect of metformin on the proliferation, apoptosis and CD133 mRNA expression of colon cancer stem cells by upregulation of miR 342\u20133p. Drug Des Devel Ther. 2021;15:4633\u201347.","journal-title":"Drug Des Devel Ther"},{"key":"3571_CR29","doi-asserted-by":"publisher","first-page":"6462793","DOI":"10.1155\/2018\/6462793","volume":"2018","author":"C Wu","year":"2018","unstructured":"Wu C, Qin N, Ren H, Yang M, Liu S, Wang Q. Metformin regulating miR-34a pathway to inhibit Egr1 in rat mesangial cells cultured with high glucose. Int J Endocrinol. 2018;2018:6462793.","journal-title":"Int J Endocrinol"},{"issue":"36","key":"3571_CR30","doi-asserted-by":"publisher","first-page":"13421","DOI":"10.1073\/pnas.0801613105","volume":"105","author":"M Yamakuchi","year":"2008","unstructured":"Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA. 2008;105(36):13421\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3571_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","volume":"32","author":"AS Kulkarni","year":"2020","unstructured":"Kulkarni AS, Gubbi S, Barzilai N. Benefits of metformin in attenuating the hallmarks of aging. Cell Metab. 2020;32(1):15\u201330.","journal-title":"Cell Metab"},{"issue":"6","key":"3571_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1159\/000502257","volume":"65","author":"HH Glossmann","year":"2019","unstructured":"Glossmann HH, Lutz O. Metformin and aging: a review. Gerontology. 2019;65(6):581\u201390.","journal-title":"Gerontology"},{"key":"3571_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2020.111350","volume":"191","author":"A Zajda","year":"2020","unstructured":"Zajda A, Huttunen KM, Sikora J, Podsiedlik M, Markowicz-Piasecka M. Is metformin a geroprotector? A peek into the current clinical and experimental data. Mech Ageing Dev. 2020;191: 111350.","journal-title":"Mech Ageing Dev"},{"issue":"23","key":"3571_CR34","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.1007\/s00018-021-03979-4","volume":"78","author":"A Raucci","year":"2021","unstructured":"Raucci A, Macri F, Castiglione S, Badi I, Vinci MC, Zuccolo E. MicroRNA-34a: the bad guy in age-related vascular diseases. Cell Mol Life Sci. 2021;78(23):7355\u201378.","journal-title":"Cell Mol Life Sci"},{"key":"3571_CR35","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190189","author":"Z Deng","year":"2019","unstructured":"Deng Z, Li Y, Liu H, Xiao S, Li L, Tian J, Cheng C, Zhang G, Zhang F. The role of sirtuin 1 and its activator, resveratrol in osteoarthritis. 2019. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20190189."},{"key":"3571_CR36","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.bone.2019.01.018","volume":"121","author":"M Almeida","year":"2019","unstructured":"Almeida M, Porter RM. Sirtuins and FoxOs in osteoporosis and osteoarthritis. Bone. 2019;121:284\u201392.","journal-title":"Bone"},{"issue":"8","key":"3571_CR37","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.joca.2009.03.002","volume":"17","author":"RF Loeser","year":"2009","unstructured":"Loeser RF. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage. 2009;17(8):971\u20139.","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"3571_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13287-019-1193-1","volume":"10","author":"X Cao","year":"2019","unstructured":"Cao X, Luo P, Huang J, Liang C, He J, Wang Z, Shan D, Peng C, Wu S. Intraarticular senescent chondrocytes impair the cartilage regeneration capacity of mesenchymal stem cells. Stem Cell Res Ther. 2019;10(1):86.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3571_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41584-020-00533-7","volume":"17","author":"PR Coryell","year":"2021","unstructured":"Coryell PR, Diekman BO, Loeser RF. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat Rev Rheumatol. 2021;17(1):47\u201357.","journal-title":"Nat Rev Rheumatol"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-03571-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-023-03571-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-03571-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:30:16Z","timestamp":1679862616000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-023-03571-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3571"],"URL":"https:\/\/doi.org\/10.1186\/s13018-023-03571-5","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"21 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiment protocols were approved by Ethics Committee of the Hainan Hospital of Chinese PLA General Hospital (approval number: S2022-10), and experimental procedures were conducted according to the Declaration of Helsinki Principles.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have declared no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}